$7.78 Billion is the total value of C WorldWide Group Holding A/S's 172 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| XOM | New | EXXON MOBIL CORP | $363,290,000 | – | 4,273,004 | +100.0% | 4.67% | – |
| AMRN | New | AMARIN CORP PLCspons adr new | $11,064,000 | – | 680,000 | +100.0% | 0.14% | – |
| NKTR | New | NEKTAR THERAPEUTICS | $4,936,000 | – | 80,975 | +100.0% | 0.06% | – |
| FOMX | New | FOAMIX PHARMACEUTICALS LTD | $3,438,000 | – | 600,000 | +100.0% | 0.04% | – |
| MCD | New | MCDONALDS CORP | $1,254,000 | – | 7,495 | +100.0% | 0.02% | – |
| KHC | New | KRAFT HEINZ CO | $1,189,000 | – | 21,583 | +100.0% | 0.02% | – |
| FNV | New | FRANCO NEVADA CORP | $923,000 | – | 14,759 | +100.0% | 0.01% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-05
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VISA INC | 37 | Q3 2023 | 15.5% |
| THERMO FISHER SCIENTIFIC INC | 37 | Q3 2023 | 11.2% |
| HDFC BANK LTD | 37 | Q3 2023 | 3.7% |
| ICICI BK LTD | 37 | Q3 2023 | 2.1% |
| CENTENE CORP DEL | 37 | Q3 2023 | 0.4% |
| DEX INC | 37 | Q3 2023 | 0.5% |
| BIOMARIN PHARMACEUTICAL INC | 37 | Q3 2023 | 0.3% |
| VERTEX PHARMACEUTICALS INC | 37 | Q3 2023 | 0.4% |
| INSULET CORP | 37 | Q3 2023 | 0.3% |
| CARA THERAPEUTICS INC | 37 | Q3 2023 | 0.2% |
View C WorldWide Group Holding A/S's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-03 |
| 13F-HR | 2024-02-05 |
| 13F-HR | 2023-11-03 |
| 13F-HR | 2023-08-02 |
| 13F-HR | 2023-05-02 |
| 13F-HR | 2023-02-03 |
| 13F-HR | 2022-11-03 |
| 13F-HR | 2022-08-02 |
| 13F-HR | 2022-05-04 |
| 13F-HR | 2022-02-02 |
View C WorldWide Group Holding A/S's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.